233 related articles for article (PubMed ID: 22307815)
1. Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?
Nyman U; Almén T; Jacobsson B; Aspelin P
Eur Radiol; 2012 Jun; 22(6):1366-71. PubMed ID: 22307815
[TBL] [Abstract][Full Text] [Related]
2. Letter to the Editor re: Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?
Stratta P; Izzo C; Canavese C; Quaglia M
Eur Radiol; 2013 May; 23(5):1260-3. PubMed ID: 23370940
[TBL] [Abstract][Full Text] [Related]
3. Reply to letter to the editor re: Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?
Nyman U; Almén T; Jacobsson B; Aspelin P
Eur Radiol; 2013 May; 23(5):1264-5. PubMed ID: 23370939
[No Abstract] [Full Text] [Related]
4. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal X-ray attenuation in renal arteriography: an experimental study in pigs.
Elmståhl B; Nyman U; Leander P; Chai CM; Frennby B; Almén T
Acad Radiol; 2004 Nov; 11(11):1219-28. PubMed ID: 15561568
[TBL] [Abstract][Full Text] [Related]
6. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.
Stacul F; van der Molen AJ; Reimer P; Webb JA; Thomsen HS; Morcos SK; Almén T; Aspelin P; Bellin MF; Clement O; Heinz-Peer G;
Eur Radiol; 2011 Dec; 21(12):2527-41. PubMed ID: 21866433
[TBL] [Abstract][Full Text] [Related]
7. Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.
Chou SH; Wang ZJ; Kuo J; Cabarrus M; Fu Y; Aslam R; Yee J; Zimmet JM; Shunk K; Elicker B; Yeh BM
Eur J Radiol; 2011 Nov; 80(2):378-86. PubMed ID: 21470810
[TBL] [Abstract][Full Text] [Related]
8. Intra-Arterial versus Intravenous Contrast and Renal Injury in Chronic Kidney Disease: A Propensity-Matched Analysis.
Chaudhury P; Armanyous S; Harb SC; Ferreira Provenzano L; Ashour T; Jolly SE; Arrigain S; Konig V; Schold JD; Navaneethan SD; Nally JV; Nakhoul GN
Nephron; 2019; 141(1):31-40. PubMed ID: 30368506
[TBL] [Abstract][Full Text] [Related]
9. Contrast-medium-Induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min.
Nyman U; Almén T; Aspelin P; Hellström M; Kristiansson M; Sterner G
Acta Radiol; 2005 Dec; 46(8):830-42. PubMed ID: 16392608
[TBL] [Abstract][Full Text] [Related]
10. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines.
Nyman U; Ahlkvist J; Aspelin P; Brismar T; Frid A; Hellström M; Liss P; Sterner G; Leander P;
Eur Radiol; 2018 Dec; 28(12):5384-5395. PubMed ID: 30132106
[TBL] [Abstract][Full Text] [Related]
11. Prevention of iodinated contrast-induced nephropathy.
Li JH; He NS
Chin Med J (Engl); 2011 Dec; 124(23):4079-82. PubMed ID: 22340345
[TBL] [Abstract][Full Text] [Related]
12. Current concepts of contrast-induced nephropathy: a brief review.
Chang CF; Lin CC
J Chin Med Assoc; 2013 Dec; 76(12):673-81. PubMed ID: 24090599
[TBL] [Abstract][Full Text] [Related]
13. [Iodinated contrast agent-induced nephropathy].
Erley C
Radiologe; 2007 Sep; 47(9):761-7. PubMed ID: 17823784
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy after intravenous administration: fact or fiction?
Katzberg RW; Lamba R
Radiol Clin North Am; 2009 Sep; 47(5):789-800, v. PubMed ID: 19744594
[TBL] [Abstract][Full Text] [Related]
15. Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.
Aslanger E; Uslu B; Akdeniz C; Polat N; Cizgici Y; Oflaz H
Coron Artery Dis; 2012 Jun; 23(4):265-70. PubMed ID: 22343798
[TBL] [Abstract][Full Text] [Related]
16. The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?
Rudnick MR; Leonberg-Yoo AK; Litt HI; Cohen RM; Hilton S; Reese PP
Am J Kidney Dis; 2020 Jan; 75(1):105-113. PubMed ID: 31473019
[TBL] [Abstract][Full Text] [Related]
17. Ultra-low iodine concentrations iso-attenuating with diagnostic 0.5M gadolinium in endovascular procedures to minimize the risk of contrast nephropathy: A phantom study.
Swanberg J; Åslund PE; Nyman RS; Nyman UR
Eur J Radiol; 2015 Jun; 84(6):1068-74. PubMed ID: 25842009
[TBL] [Abstract][Full Text] [Related]
18. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.
Owen RJ; Hiremath S; Myers A; Fraser-Hill M; Barrett BJ
Can Assoc Radiol J; 2014 May; 65(2):96-105. PubMed ID: 24559602
[TBL] [Abstract][Full Text] [Related]
19. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
[TBL] [Abstract][Full Text] [Related]
20. Reducing the risks for contrast-induced nephropathy.
Stacul F
Cardiovasc Intervent Radiol; 2005; 28 Suppl 2():S12-8. PubMed ID: 16419278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
